What this topic covers
CAR-T literature spans hematology, solid tumors, autoimmune disease, target discovery, antigen escape, cytokine release syndrome, neurotoxicity, and persistence of engineered T cells.
Topic feed
Recent CAR-T Cell Therapy Papers
Follow new research on chimeric antigen receptor T cells, including cell engineering, clinical outcomes, relapse biology, toxicity, manufacturing, and immune monitoring.
How to use this feed
Start broad with CAR-T, then refine inside PaprFeed by source, date range, or phrases such as BCMA CAR-T, CD19 CAR-T, solid tumor CAR-T, allogeneic CAR-T, or CAR-T toxicity.
Search ideas
Useful searches to try next
Research context
How to read this topic
What papers are useful here?
Clinical trials, translational oncology studies, immunology papers, safety reports, and preprints describing new CAR designs are all useful signals.
Which sources matter most?
PubMed is usually strongest for published clinical literature, while bioRxiv and medRxiv can surface earlier mechanistic or clinical-preprint signals.